PPHVanEck Pharmaceutical ETF
Fund Description
VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS®US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
-
Fund Ticker
PPH -
Exchange
NASDAQ -
ETF Structure
Physical -
Administrator
Van Eck Associates -
Custodian
State Street Bank and Trust Company -
Index Ticker
MVPPHTR -
Index Rebalancing
Quarterly
as of 09/23/21
-
30-Day SEC Yield1
1.64% -
Total Net Assets
$323.9M -
Number of Holdings
25 -
Options
Available -
Gross Expense Ratio2
0.42% -
Net Expense Ratio/TER2
0.35% -
Distribution Frequency
Quarterly
Documents and Downloads
-
Name
Update Schedule
- Annually
- Annually
- Annually
-
Statement of Additional Information (SAI)
Annually - Annually
- Annually
-
VanEck Yearend Dividends/Distributions
Annually -
NAV & Premium/Discount History
Daily - Daily